Feedback / Questions
Leqembi (lecanemab-irmb) - Biogen, Eisai
The use of blood biomarkers to understand responses to lecanemab treatment.
(PubMed, Lancet Neurol)
-
Sep 25, 2026 -
No abstract available
Biomarker • Journal
http://www.ncbi.nlm.nih.gov/pubmed/42785334
Natalie S Ryan
Sep 25, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next